| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |